Medexus Pharmaceuticals (MEDXF) Earnings Date & Reports

Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MEDXF is expected to report earnings to fall 265.00% to -3 cents per share on November 05

Medexus Pharmaceuticals MEDXF Stock Earnings Reports

Q3'25

Est.

$-0.03

Q2'25

Beat

by $0.07

Q1'25

Beat

by $0.05

The last earnings report on August 12 showed earnings per share of 1 cents, beating the estimate of -5 cents. With 56.75K shares outstanding, the current market capitalization sits at 69.19M.

View a ticker or compare two or three

Compare

MEDXF

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MEDXF
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MEDXF showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry PharmaceuticalsGeneric

Profile

Fundamentals

Details

Industry

N/A

Address

35 Nixon Road

Phone

+1 514 344-8765

Employees

Web

https://www.medexus.com